Gene: CDCA3
Official Full Name: cell division cycle associated 3provided by HGNC
Gene Summary: Predicted to be involved in cell division and protein ubiquitination. Located in adherens junction. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25491 | CDCA3 Knockout cell line (HeLa) | Human | CDCA3 | 1:3~1:6 | Negative | Online Inquiry |
KO25492 | CDCA3 Knockout cell line (HCT 116) | Human | CDCA3 | 1:2~1:4 | Negative | Online Inquiry |
KO25493 | CDCA3 Knockout cell line (HEK293) | Human | CDCA3 | 1:3~1:6 | Negative | Online Inquiry |
KO25494 | CDCA3 Knockout cell line (A549) | Human | CDCA3 | 1:3~1:4 | Negative | Online Inquiry |
CDCA3 Gene Knockout Cell Lines represent a specialized tool for the exploration of cell cycle regulation, unveiling the functional roles of the CDCA3 gene in various biological processes. These knockout cell lines have been genetically modified to remove the expression of the CDCA3 gene, allowing researchers to investigate its contributions to cell proliferation, tumorigenesis, and other critical cellular mechanisms without the interference of this gene's functions.
Fundamentally, CDCA3 (Cell Division Cycle Associated 3) is implicated in the regulation of mitotic processes and influences cell cycle progression. By using CDCA3 knockout cell lines, scientists can elucidate the gene’s role in cancer biology and assess how its absence affects signaling pathways that govern cell division and differentiation. This model not only emphasizes the cellular response to DNA damage and stress but also provides insights into potential therapeutic targets for cancer treatment.
The scientific importance of CDCA3 knockout cell lines is underscored by their applications in cancer research, drug discovery, and understanding fundamental aspects of cell cycle control. As researchers increasingly seek reliable models to study gene functions, these knockout cell lines offer a clear advantage in providing specific insights into the role of CDCA3 without the confounding effects of functional gene activity found in wild-type cell lines.
Compared to commercially available alternatives, our CDCA3 gene knockout cell lines are rigorously validated for gene targeting efficiency and functional outcomes, ensuring reproducibility in experimental results. They are available in multiple cell types tailored to diverse applications, enhancing their versatility.
For researchers and clinicians focused on cancer biology and cell cycle research, the value of CDCA3 knockout cell lines lies in their potential to advance understanding of oncogenic processes and facilitate high-throughput screening for drug candidates. With our commitment to high-quality biological products and robust customer support, our company stands as a trusted leader in providing state-of-the-art research tools that drive scientific discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.